Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Flow Cytometry in Oncology and Immunology Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Immunology, Oncology)
5.2.2. By Technology (Cell-based flow cytometry, Bead-based flow cytometry)
5.2.3. By Offering (Reagents, Instruments, and Consumables Software)
5.2.4. By Application (Translational Research, Clinical Research)
5.2.5. By End User (Hospitals, Diagnostic Laboratories, and Reference Laboratories, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others)
5.2.6. By Region (North America, Europe, Asia Pacific, South America, Middle East and Africa)
5.2.7. By Company (2022)
5.3. Market Map
5.3.1. By Type
5.3.2. By Technology
5.3.3. By Offering
5.3.4. By Application
5.3.5. By End User
5.3.6. By Region
6. North America Flow Cytometry in Oncology and Immunology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Technology
6.2.3. By Offering
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Flow Cytometry in Oncology and Immunology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Technology
6.3.1.2.3. By Offering
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Flow Cytometry in Oncology and Immunology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Technology
6.3.2.2.3. By Offering
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Flow Cytometry in Oncology and Immunology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Technology
6.3.3.2.3. By Offering
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Flow Cytometry in Oncology and Immunology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Technology
7.2.3. By Offering
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Flow Cytometry in Oncology and Immunology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Technology
7.3.1.2.3. By Offering
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. France Flow Cytometry in Oncology and Immunology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Technology
7.3.2.2.3. By Offering
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Flow Cytometry in Oncology and Immunology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Technology
7.3.3.2.3. By Offering
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Flow Cytometry in Oncology and Immunology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Technology
7.3.4.2.3. By Offering
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Flow Cytometry in Oncology and Immunology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Technology
7.3.5.2.3. By Offering
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Technology
8.2.3. By Offering
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Flow Cytometry in Oncology and Immunology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Technology
8.3.1.2.3. By Offering
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. Japan Flow Cytometry in Oncology and Immunology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Technology
8.3.2.2.3. By Offering
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. India Flow Cytometry in Oncology and Immunology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Technology
8.3.3.2.3. By Offering
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Flow Cytometry in Oncology and Immunology Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Technology
8.3.4.2.3. By Offering
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Flow Cytometry in Oncology and Immunology Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Technology
8.3.5.2.3. By Offering
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. South America Flow Cytometry in Oncology and Immunology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Technology
9.2.3. By Offering
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Flow Cytometry in Oncology and Immunology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Technology
9.3.1.2.3. By Offering
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Flow Cytometry in Oncology and Immunology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Technology
9.3.2.2.3. By Offering
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Flow Cytometry in Oncology and Immunology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Technology
9.3.3.2.3. By Offering
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Middle East and Africa Flow Cytometry in Oncology and Immunology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Technology
10.2.3. By Offering
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Flow Cytometry in Oncology and Immunology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Technology
10.3.1.2.3. By Offering
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Flow Cytometry in Oncology and Immunology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Technology
10.3.2.2.3. By Offering
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. South Africa Flow Cytometry in Oncology and Immunology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Technology
10.3.3.2.3. By Offering
10.3.3.2.4. By Application
10.3.3.2.5. By End User
10.3.4. Turkey Flow Cytometry in Oncology and Immunology Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type
10.3.4.2.2. By Technology
10.3.4.2.3. By Offering
10.3.4.2.4. By Application
10.3.4.2.5. By End User
10.3.5. Egypt Flow Cytometry in Oncology and Immunology Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Type
10.3.5.2.2. By Technology
10.3.5.2.3. By Offering
10.3.5.2.4. By Application
10.3.5.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.1.1. Rising Prevalence of Cancer Cases
11.1.2. Advancement in Technology
11.1.3. Recent Developments & Product Launches
11.2. Challenges
11.2.1. High Cost of the Products of the Flow Cytometry Equipment
11.2.2. False antibody responses
12. Market Trends & Developments
13. Competitive Landscape
13.1. Business Overview
13.2. Product Offerings
13.3. Recent Developments
13.4. Financials (As Reported)
13.5. Key Personnel
13.5.1. Danaher Corporation
13.5.2. Merck KGaA
13.5.3. Miltenyi Biotec
13.5.4. Neo-Genomics Laboratories, Inc.
13.5.5. Thermo Fisher Scientific Inc
13.5.6. Cell Signaling Technology, Inc
13.5.7. Becton, Dickinson and Company
13.5.8. Agilent Technologies, Inc.
13.5.9. DiaSorin S.p.A (Luminex Corporation)
13.5.10. OPKO Health, Inc.
14. Strategic Recommendations